235 related articles for article (PubMed ID: 23052653)
1. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.
Kumar J; Shatat IF; Skversky AL; Woroniecki RP; Del Rio M; Perelstein EM; Johnson VL; Mahesh S
Pediatr Nephrol; 2013 Feb; 28(2):333-8. PubMed ID: 23052653
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
[TBL] [Abstract][Full Text] [Related]
3. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
Alachkar N; Li J; Matar D; Vujjini V; Alasfar S; Tracy M; Reiser J; Wei C
BMC Nephrol; 2018 Dec; 19(1):361. PubMed ID: 30558559
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
5. Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab.
Koutroutsos K; Charif R; Moran L; Moss J; Cook T; Roufosse C; Pusey C; Taube D; Loucaidou M
Clin Exp Nephrol; 2019 May; 23(5):700-709. PubMed ID: 30637591
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
[TBL] [Abstract][Full Text] [Related]
7. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
Dęborska-Materkowska D; Kozińska-Przybył O; Mikaszewska-Sokolewicz M; Durlik M
Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
[TBL] [Abstract][Full Text] [Related]
9. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
10. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E
Am J Nephrol; 2017; 46(2):108-113. PubMed ID: 28700988
[TBL] [Abstract][Full Text] [Related]
11. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen.
Stewart ZA; Shetty R; Nair R; Reed AI; Brophy PD
Transplant Proc; 2011 Dec; 43(10):3994-6. PubMed ID: 22172885
[TBL] [Abstract][Full Text] [Related]
12. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
Ino A; Kaori S; Takei T; Nitta K
CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
15. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis.
Hansrivijit P; Ghahramani N
Int Urol Nephrol; 2020 Jul; 52(7):1377-1387. PubMed ID: 32306197
[TBL] [Abstract][Full Text] [Related]
16. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
Yabu JM; Ho B; Scandling JD; Vincenti F
Am J Transplant; 2008 Jan; 8(1):222-7. PubMed ID: 17979998
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB
Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884
[TBL] [Abstract][Full Text] [Related]
18. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
[TBL] [Abstract][Full Text] [Related]
19. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.
Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV
Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922
[TBL] [Abstract][Full Text] [Related]
20. Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort.
Allard L; Kwon T; Krid S; Bacchetta J; Garnier A; Novo R; Deschenes G; Salomon R; Roussey G; Allain-Launay E
Nephrol Dial Transplant; 2018 Jun; 33(6):954-963. PubMed ID: 28992235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
